Navigation Links
Another industry first enabled by Benchmark Biolabs - Peros' oral delivery platform and vaccine facility licensed by the USDA
Date:4/15/2008

LINCOLN, NE, April 15 /PRNewswire/ - The acceptance of Peros' oral delivery platform and vaccine facility by the USDA marks another significant achievement by Benchmark Biolabs, a full service biopharmaceutical product development firm.

Benchmark Biolabs designed, constructed and oversees the operation and management of the Peros production facility which is co-located on Benchmark's R&D and manufacturing biotechnology campus in Lincoln, NE.

By obtaining approval by the USDA, Peros, a pioneering biotechnology company that has developed unique natural product formulation methods enabling oral delivery of biopharmaceutical compounds, is now well positioned to begin product commercialization of its oral delivery platform.

"Had it not been for Benchmark's stage-gated "BEAM(TM)" approach to our project from validation to licensure, our technology would have been yet another promising biotech discovery that would never have reached its commercial potential.", stated Dr. Grant Vandenberg, CSO and Founder of Peros.

Benchmark and Peros are excited to offer this first-in-class oral delivery technology platform that will significantly enhance the actual value of vaccines. The licensed platform offers a labor minimizing, practical method for oral delivery of prophylactic and therapeutic products for the livestock industry as well as traditional animal health company opportunities to expand the oral enablement of the industry as a whole.

"Benchmark's mission is to design and implement, with our clients, an efficient product development process - delivering critical expertise, technologies, facilities, ideas and services, in a seamless and integrated offering", added Tom Overbay, Vice-President of Business Development for Benchmark Biolabs.

Peros' licensure marks another significant and innovative first obtained by Benchmark over their 11-year history. At the Benchmark campus there are now three licensed manufacturing facilities wh
'/>"/>

SOURCE Benchmark Biolabs
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Signalife Receives Another $3.3 Million Sales Orders
2. Dalton Medicinal Chemistry Partners Achieves Another Milestone in Collaboration with Boehringer Ingelheim (Canada) Ltd.
3. 2007 Another Record Year in Terms of Sales and Earnings for Gerresheimer
4. Ohio Ranks Best in the Midwest for Venture Capital Investment in Health Care Bioscience Industry
5. Advanced Cell Technologys Dr. Robert Lanza Makes List of 100 Most Inspiring People in the Life-Sciences Industry
6. Nabi Biopharmaceuticals to Present at Upcoming Industry Conferences
7. Favrille CEO to Present at NewsMakers in the Biotech Industry Investment Conference
8. NeurogesX to Present at BioCenturys NewsMakers in the Biotech Industry Conference
9. DURECT Corporation to Present at the NewsMakers in the Biotech Industry Investment Conference
10. TorreyPines Therapeutics to Present at the NewsMakers in the Biotech Industry Conference
11. Neurocrine Biosciences to Present at the BioCentury: Newsmakers in the Biotech Industry Conference

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/18/2009)...erience in data analysis combined with Bio-Rad,s ...s and curricula provide state-of-the-art solutions...., Nov. 18 Vernier Software & ...rfaces, sensors, and software and Bio-Rad Laborato...ibutor of life science research and clinical diagn...
(Date:11/18/2009)...West Sussex, U.K. and CLEVELAND, Nov. 18 /PRNewswi...nces business and premier provider of diagnostic s...y labs, has expanded its East Grinstead, U.K., man...o meet increasing global demand for its Sensititre...ication testing. The expanded facility has been fu...
(Date:11/18/2009)...Nov. 18 /PRNewswire-FirstCall/ - YM BioSciences In...oduct development company that identifies and adva...ed products at various stages of development, anno...umab were presented today in a poster at the 2009 ...eutics conference in Boston, Massachusetts. The re...
(Date:11/18/2009)..., Fla., Nov. 18 Algenol Biofuels L...gy, and the technology group The Linde Group hav...ject in order to identify the optimum management o...,s unique algae and photobioreactor technology. Th...to develop cost-efficient technologies that captur...
Breaking Biology Technology:Vernier and Bio-Rad to Offer Enhanced Solutions for Biotechnology Education 2TREK Diagnostic Systems Opens New U.K. Facility in East Grinstead to Meet Expanded Customer Demand for Microbiology Products 2TREK Diagnostic Systems Opens New U.K. Facility in East Grinstead to Meet Expanded Customer Demand for Microbiology Products 3TREK Diagnostic Systems Opens New U.K. Facility in East Grinstead to Meet Expanded Customer Demand for Microbiology Products 4YM BIOSCIENCES ANNOUNCES NIMOTUZUMAB RESULTS IN ADVANCED TRIPLE-NEGATIVE BREAST CANCER MODEL PRESENTED AT AACR-NCI-EORTC MEETING 2YM BIOSCIENCES ANNOUNCES NIMOTUZUMAB RESULTS IN ADVANCED TRIPLE-NEGATIVE BREAST CANCER MODEL PRESENTED AT AACR-NCI-EORTC MEETING 3Algenol Biofuels and The Linde Group Agree To Cooperate in CO2 and O2 Management For Biofuel Production From Algae 2Algenol Biofuels and The Linde Group Agree To Cooperate in CO2 and O2 Management For Biofuel Production From Algae 3
...ts with acute coronary syndrome (ACS) undergoing a...eatment option to help prevent heart attacks. Dai...illy and Company (NYSE: LLY ) announced today th...uthorization for EFIENT (R) (pronounced Ef-ee-ent...otic events in patients with ACS undergoing percut...
...treatment for infants with hearing problems, and t...e two very different possible outcomes of some &qu... Brussels, Belgium (PRWEB) February 23, 20... screening and treatment for infants with hearing ...ical scores, are two very different possible outco...
...s Association reminds U.S. Bt corn growers that th...lan is an essential and required part of their pla...s, MO (PRWEB) February 20, 2009 -- As the 2009 pl...ssociation (NCGA) reminds U.S. Bt corn growers th...ment (IRM) plan is an essential and required part...
Other Biology Technology:European Commission Approves EFIENT(R) (prasugrel) for Patients with Acute Coronary Syndrome Undergoing PCI 2European Commission Approves EFIENT(R) (prasugrel) for Patients with Acute Coronary Syndrome Undergoing PCI 3European Commission Approves EFIENT(R) (prasugrel) for Patients with Acute Coronary Syndrome Undergoing PCI 4European Commission Approves EFIENT(R) (prasugrel) for Patients with Acute Coronary Syndrome Undergoing PCI 5Babies Learn Music While Sleeping 2Babies Learn Music While Sleeping 3Babies Learn Music While Sleeping 4Corn Growers Reminded to Follow Refuge Requirements as Spring Planting Nears 2Corn Growers Reminded to Follow Refuge Requirements as Spring Planting Nears 3
(Date:11/20/2009)... abstracts to the World Congress on Osteoporosis 2... devoted to all aspects of osteoporosis and osteoa...ill be held in Florence, Italy from May 5-8, 2010....nline at http://www.iofwco-ecceo10.org , The ...nd ESCEO are pleased to announce that seven specia...
(Date:11/20/2009)...e estimated 4.6 million Americans involved in the ...ratory symptoms due to poor air quality in horse b...n earlier this year by investigators at Tufts Univ..., The studywhich polled more than 80 New England ...uals working in barns complained of coughing, whee...
(Date:11/20/2009)...ess an ingenious mechanism for preventing oxygen f...is the new finding of a team of biologists that in...rch institute in Flanders, Belgium, connected to t... this discovery by modifying the DNA of the intest...s model organism, they have uncovered the existenc...
Breaking Biology News(10 mins):Special sessions announced for World Congress on Osteoporosis 2010 - IOF WCO - ECCEO10 2Special sessions announced for World Congress on Osteoporosis 2010 - IOF WCO - ECCEO10 3Barn personnel experience higher-than-average rates of respiratory symptoms 2Biologists discover bacterial defense mechanism against aggressive oxygen 2CVS Caremark Announces Updates to Flu Vaccine Program 5512 1CVS Caremark Announces Updates to Flu Vaccine Program 5512 2CVS Caremark Announces Updates to Flu Vaccine Program 5512 3Smog Tougher on the Obese 59542 1Smog Tougher on the Obese 59542 2Smog Tougher on the Obese 59542 3Findings about veracity of peripheral vision could lead to better robotic eyes 59538 1Findings about veracity of peripheral vision could lead to better robotic eyes 59538 2
... 2009Los Alamos National Laboratory researchers ha...bers that make the cell walls of certain inedible ...ould lead to a cost-effective and energy-efficient...ls. , In separate papers published today in Biop...acromolecules , Los Alamos researchers identify po...
...Leeds have developed chemicals which kill the most...iparum including those resistant to existing dru... dihydroorotate dehydrogenase (DHODH) - essential ...h results in its death. , Says lead researcher Dr ...Sciences: "Without this enzyme, Plasmodium falcip...
...9 Olympus America Inc. formally introduced its ad...s to perform minimally invasive single-site surger...result in less abdominal trauma, less post-operati...ved recovery for patients. The platform, introduce...al and Endoscopic Surgeons meeting, combines exist...
Other Biology News:Breaking the ties that bind: New hope for biomass fuels 2New hope for advances in treating malaria 2Olympus advances technology for laparo-endoscopic single-site surgery 2
Human Serum Type AB from Irvine Scientific
PPase-2A from Promega
X-Gal from Research Organics, Inc.
TNT® T7 Quick Coupled Transcription/Translation System from Promega
Biology Products: